PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsSuccinylcholine
Suxamethonium
Suxamethonium is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against acetylcholine receptor subunit alpha.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
167 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Depressive disorderD003866EFO_1002014F32.A1——4712
DepressionD003863—F33.9———5712
AnesthesiaD000758—————358
Neuromuscular blockadeD019148———11327
Intratracheal intubationD007442———11226
DiseaseD004194EFO_0000408R69—1—225
IntubationD007440—————145
Bipolar disorderD001714EFO_0000289F30.9———415
Major depressive disorderD003865EFO_0003761F22———235
DyslipidemiasD050171——2——114
Show 49 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MyalgiaD063806—M79.1—24—37
Prostatic neoplasmsD011471—C61—22—25
FasciculationD005207—R25.3——2—24
Substance-related disordersD019966EFO_0003890F13—21—13
GlaucomaD005901EFO_0000516H40——1—23
ShockD012769—R57.1——2——2
ObesityD009765EFO_0001073E66.9—11—12
Wounds and injuriesD014947—T14.8——1—12
ManiaD000087122—F30——1—12
Open-angle glaucomaD005902EFO_0004190H40.1——1—12
Show 13 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———61——39
HypertriglyceridemiaD015228EFO_0004211—11——13
HypersensitivityD006967EFO_0003785T78.40—1——12
FibrosisD005355———1——12
Cystic fibrosisD003550EFO_0000390E84—1——12
Gastric bypassD015390EFO_0005244——1———1
Heart diseasesD006331EFO_0003777I51.9—1———1
Heart valve diseasesD006349EFO_0009551I08—1———1
Macular edemaD008269———1———1
EdemaD004487—R60.9—1———1
Show 2 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cardiovascular diseasesD002318EFO_0000319I982————2
Diet therapyD004035——1———12
Hepatolenticular degenerationD006527Orphanet_905E83.012————2
Child developmentD002657——1———12
Food diet and nutritionD000066888——1————1
PharmacokineticsD010599——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MalnutritionD044342EFO_0008572E40-E46————33
Heart disease risk factorsD000082742——————33
Patient satisfactionD017060——————22
PainD010146EFO_0003843R52————22
Non-alcoholic fatty liver diseaseD065626EFO_0003095K75.81————22
ArthritisD001168EFO_0005856M05-M14————11
PharyngitisD010612—R07.0————11
Body weightD001835EFO_0004338—————11
Body weight changesD001836——————11
Pancreatic diseasesD010182—K86.9————11
Show 54 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSuxamethonium
INNsuxamethonium chloride
Description
Succinylcholine is a quaternary ammonium ion that is the bis-choline ester of succinic acid. It has a role as a neuromuscular agent, a muscle relaxant and a drug allergen. It is a quaternary ammonium ion and a succinate ester.
Classification
Small molecule
Drug classquaternary ammonium derivatives; quaternary ammonium derivatives
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
Identifiers
PDB—
CAS-ID306-40-1
RxCUI—
ChEMBL IDCHEMBL703
ChEBI ID45652
PubChem CID5314
DrugBankDB00202
UNII IDJ2R869A8YF (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,875 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use